Hadassah

Thyroid Cancer Diagnosis Enhanced at Hadassah Using Advanced Gene Sequencing

Thursday, Aug 2 2018

left: Dr.Iddo Ben-Dov and right: Prof.Haggi Mazeh

Hadassah Medical Organization researchers, using next generation sequencing (NGS), have identified a highly accurate RNA panel that distinguishes thyroid cancer from benign nodules.

The study, authored by Prof. Haggi Mazeh, Chief of Surgery at Hadassah Hospital Mount Scopus, and Hadassah Nephrologist Dr. Iddo Ben-Dov, is highlighted in the July 26, 2018 on line issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

As the authors explain, fine needle aspiration biopsy (FNAB), the gold-standard procedure for diagnosing malignant thyroid nodules, yields indeterminate cytology in 10 to 40 percent of cases. The aim of their study was to utilize NGS technology to identify diversities in the microRNA expression profile of benign versus malignant thyroid nodules. MicroRNAs are short, non-coding RNAs that regulate cell function and play a role in cancer development.

"Thyroid nodules are extremely common and occasionally harbor cancer," explains Prof. Mazeh. "Patients who undergo evaluation of thyroid nodules often receive ambiguous results, and there are currently limited options for further management, representing a clinically unmet need."

“Our panel,” the researchers concluded, “may classify indeterminate thyroid nodules with higher accuracy than commercially available molecular tests.”

Read more about this study in Medical Xpress.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jun 19 2019

Happiness in the Intensive Care Unit: A Father Expresses His Anticipatory Joy

“My name is Yoel Fadel. Today is a very special day for me. My youngest son, Benny, is getting married. He will walk to the wedding canopy with his sweetheart, but I cannot attend the wedding.

READ MORE ›
alt_text

Wednesday, Jun 19 2019

Helping with a Full Heart: A Mitzvah Passed on at Hadassah Mount Scopus

They met in the Pediatrics Department at Hadassah Hospital Mount Scopus, two couples whose children suffer from a rare disease.

READ MORE ›
alt_text

Tuesday, Jun 18 2019

Diabetes: An Ongoing Struggle

Prof. Gil Leibowitz, head of the Diabetes Unit at the Hadassah Medical Organization’s Endocrinology and Metabolism Service, remembers himself as a scared, skinny seven-year-old when the doctor told his parents that he had type 1 diabetes.

READ MORE ›
alt_text

Wednesday, Jun 12 2019

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

In a large multinational study that revealed the effectiveness of a medicine called dapagliflozin in reducing cardiovascular death from heart failure among high-risk diabetic patients, the first sub-analysis of renal data has also identified a 47 percent drop in decline of kidney function and renal death.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More